Research paper
Host Defense Peptide-Mimicking Amphiphilic β-Peptide Polymer (Bu:DM) Exhibiting Anti-Biofilm, Immunomodulatory, and in Vivo Anti-Infective Activity
About this item
- Title
- Host Defense Peptide-Mimicking Amphiphilic β-Peptide Polymer (Bu:DM) Exhibiting Anti-Biofilm, Immunomodulatory, and in Vivo Anti-Infective Activity
- Content partner
- University of Otago
- Collection
- Otago University Research Archive
- Description
Therapeutic options to treat multidrug resistant bacteria, especially when present in biofilms, are limited due to their high levels of antibiotic resistance. Here, we report the anti-biofilm and immunomodulatory activities of the host defense peptide (HDP)-mimicking β-peptide polymer (20:80 Bu:DM) and investigated its activity . The polymer outperformed antibiotics in the removal and reduction of the viability of established biofilms, achieving a maximum activity of around 80% reduction in v...
- Format
- Research paper
- Research format
- Scholarly text / Journal article
- Thesis level
- Article
- Date created
- 2020-11-12
- Creator
- Etayash, Hashem / Qian, Yuxin / Pletzer, Daniel / Zhang, Qiang / Xie, Jiayang / Cui, Ruxin / Dai, Chengzhi / Ma, Pengcheng / Qi, Fan / Liu, Runhui / Hancock, Robert E W
- URL
- https://hdl.handle.net/10523/19595
- Related subjects
- Animals / Anti-Bacterial Agents - pharmacology / Anti-Infective Agents - chemistry / Anti-Infective Agents - pharmacology / Anti-Infective Agents - therapeutic use / Antimicrobial Cationic Peptides - chemistry / Biofilms - drug effects / Cell Survival - drug effects / Cytokines - pharmacology / Disease Models, Animal / Humans / Immunity, Innate - drug effects / Leukocytes, Mononuclear - cytology / Leukocytes, Mononuclear - drug effects / Leukocytes, Mononuclear - metabolism / Methicillin-Resistant Staphylococcus aureus / Microbial Sensitivity Tests / Peptidomimetics / Polymers - chemistry / Polymers - pharmacology / Polymers - therapeutic use / Pseudomonas aeruginosa - drug effects / Pseudomonas aeruginosa - physiology / Skin Diseases - drug therapy / Skin Diseases - microbiology / Skin Diseases - pathology
What can I do with this item?
Check copyright status and what you can do with this item
Check informationReport this item
If you believe this item breaches our terms of use please report this item
Report this itemDigitalNZ brings together more than 30 million items from institutions so that they are easy to find and use. This information is the best information we could find on this item. This item was added on 03 May 2024, and updated 09 October 2024.
Learn more about how we work.
Share
What is the copyright status of this item?

All Rights Reserved
This item is all rights reserved, which means you'll have to get permission from University of Otago before using it.
What can I do with this item?
You must always check with University of Otago to confirm the specific terms of use, but this is our understanding:

Non-infringing use
NZ Copyright law does not prevent every use of a copyright work. You should consider what you can and cannot do with a copyright work.

No sharing
You may not copy and/or share this item with others without further permission. This includes posting it on your blog, using it in a presentation, or any other public use.

No modifying
You are not allowed to adapt or remix this item into any other works.

No commercial use
You may not use this item commercially.
What can I do with this item?
Check copyright status and what you can do with this item
Check informationReport this item
If you believe this item breaches our terms of use please report this item
Report this itemDigitalNZ brings together more than 30 million items from institutions so that they are easy to find and use. This information is the best information we could find on this item. This item was added on 03 May 2024, and updated 09 October 2024.
Learn more about how we work.
Share
Related items
Loading...